Audio | Renovascular revascularization | Stenting

Podcast 65: A conversation about the utility of renovascular angioplasty in the face of atherosclerosis

Posted by Journal Watch Editors on November 13th, 2009
 
icon for podpress  Standard Podcast: Play Now | Play in Popup | Download

Investigators have suspected that there isn’t much advantage to renovascular angioplasty and stenting in atherosclerosis, but their studies haven’t had the statistical power to prove that point. A new bit of research in this week’s New England Journal of Medicine may have hit the mark. We’ve got an interview with two of the principals of the ASTRAL study (that’s their acronym for Angioplasty and Stenting for Renal Artery Lesions). Dr. Philip Kalra, the nephrology lead, and Dr. Jonathan Moss, the radiology lead, kindly agreed to the conversation, which I think you’ll find of interest.

Reach us with your comments and suggestions at jelia@jwatch.org, or call 1-617-440-4374.

This edition’s links:

Interview link–

News links–


CABG | Heart-Lung Machine | surgery

Podcast 64: A conversation regarding on-pump versus off-pump CABG with Frederick Grover.

Posted by Journal Watch Editors on November 12th, 2009
 
icon for podpress  Standard Podcast: Play Now | Play in Popup | Download

Avoiding use of the heart-lung machine during coronary artery bypass grafting was supposed to lower neurocognitive problems and other complications after the procedure. A large randomized trial finds otherwise. We’ve got a conversation with one of the investigators, Frederick Grover.

To contact us, call 1-617-440-4374. You can write to me at jelia@jwatch.org.

This week’s links:

News links:

Interview links:


antipsychotic drugs

Podcast 63: A conversation about the adverse cardiometabolic effects of second-generation antipsychotic drugs in young patients with Christoph Correll

Posted by Journal Watch Editors on November 2nd, 2009
 
icon for podpress  Standard Podcast: Play Now | Play in Popup | Download

There are consequences of even short-term use of some drugs. Take the second-generation antipsychotics. A 3-month course can cause weight gain of almost 20 pounds in young people, according to a JAMA study. We interview Dr. Christoph Correll about the implications.

To reach Clinical Conversations, you can call 1-617-440-4374 or email me at jelia@jwatch.org.

This weeks news and interview links:

News:

Interview: